NAD(P)H:quinone oxidoreductase (NMO1; IEC 1.6,99.2), also called DT-diaphor
ase, is involved in the reduction of coenzyme Q, an important cellular lipo
philic antioxidant that can function as an intermediate electron carrier in
plasma membrane-associated electron transport regulating cell growth. We e
xamined the ability of normal human trabecular osteoblastic cells to expres
s NAD(P)H:quinone oxidoreductase (NMO1) and studied its modulation during c
ell proliferation and growth arrest, We found that confluent primary human
trabecular osteoblastic cells derived from healthy individuals constitutive
ly express NMO1 activity, measured using 2-6 dichlorophenol indophenol (DCI
) or menadione (vitamin K3) as substrate, and NADPH or NADH as electron don
or, We also found that NMO1 activity was related to osteoblastic cell growt
h. NMO1 activity increased with osteoblastic cell density, Confluent growth
-arrested cells expressed an eightfold higher NMO1 specific activity than p
roliferative human osteoblastic cells. Reverse-transcription polymerase cha
in reaction analysis showed that NMO1 mRNA levels did not differ in growth-
arrested confluent cell and growing cells, suggesting that the increased NM
O1 activity with cell density was due to posttranslational events. Harvesti
ng and replating the cells at low density resulted in a 93.4% loss of NMO1
enzymatic activity. Removal of serum from high-density growth-arrested cell
s resulted in a 48.5% decrease in NMO1 activity. NMO1 activity does not app
ear to be related to induction of osteoblast differentiation because treatm
ent with the differentiating agent 1,25(OH)(2) vitamin D-3 had no effect on
NMO1 activity, The finding that human osteoblastic cells express NMO1 cons
titutively and that NMO1 activity increases with density-dependent growth i
nhibition suggest a role for NAD(P)H:quinone oxidoreductase in the control
of growth arrest in normal human osteoblastic cells. (C) 2001 by Elsevier S
cience Inc. All rights reserved.